Advertisement

Aesthetic Plastic Surgery

, Volume 33, Issue 3, pp 440–444 | Cite as

Safety and Effectiveness of Mentor’s MemoryGel Implants at 6 Years

  • Bruce CunninghamEmail author
  • Jonathan McCue
Original Article

Abstract

Background

In November 2006, the FDA approved the Premarket Approval PMA applications for the round, cohesive, silicone gel-filled breast implants of Mentor (MemoryGel) and Allergan. Since that time, the devices have been widely available to plastic surgeons and their use is rapidly eclipsing that of the saline breast implants. Patients in the Core clinical studies supporting these approvals continue to be followed through for 10 years, with comprehensive annual patient and physician-reported evaluations of safety and efficacy.

Methods

One thousand and eight (1,008) female patients had data collected on 1,898 implants, and were enrolled at 48 sites. Key complication rates were recorded with Kaplan–Meier estimated cumulative incidence calculation for each.

Results

Rupture rate, suspected and confirmed, for primary augmentation was 1.1% (95% CI, 0.3–4.3), and that for primary reconstruction patients was 3.8% (95% CI, 1.4–9.8). Capsular contracture rates for clinically significant Baker III/IV contracture for primary augmentation was 9.8% (95% C I, 7.6–12.7), and that for primary reconstruction was 13.7% (95% CI, 9.7–19.1). The reoperation incidence for primary augmentation and primary reconstruction was 19.4 and 33.9%, respectively, with explantation and replacement with a study device in 3.9% of primary augmentations and 10.4% of primary reconstructions.

Conclusions

Mentor MemoryGel Silicone Breast implants represent a safe and effective choice for women seeking breast augmentation or breast reconstruction following mastectomy.

Keywords

Mentor Silicone breast implants Safety Effectiveness Outcomes Follow-up Rupture Complications 

References

  1. 1.
    Transcript of the FDA Panel, Mentor hearings (April 2005). Available at http://www.fda.gov/ohrms/dockets/ac/05/transcripts/2005-4101t3.doc. Accessed 6 May 2009
  2. 2.
    FDA Summary Panel Memorandum: Mentor P030053. Available at http://www.fda.gov/ohrms/dockets/ac/05/briefing/2005-4101b1_Tab-1_fda-Mentor%20Panel%20Memo.pdf. Accessed 6 May 2009
  3. 3.
    Cunningham BL (2007) The Mentor Core Study on silicone MemoryGel breast implants. Plast Reconstr Surg 120(7 Suppl 1):19S–29SPubMedCrossRefGoogle Scholar
  4. 4.
    Spear SL, Murphy DK, Slicton A, Walker PS (2007) Inamed silicone breast implant core study results at 6 years. Plast Reconstr Surg 120(7 Suppl 1):8S–16SPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC and International Society of Aesthetic Plastic Surgery 2009

Authors and Affiliations

  1. 1.Division of Plastic and Reconstructive SurgeryUniversity of Minnesota Medical SchoolMinneapolisUSA

Personalised recommendations